Evidence map›Paper›PMID 28159066›Full record

ReviewAmerican journal of infection control2017

The new frontier of diagnostics: Molecular assays and their role in infection prevention and control.

Sanchita Das, Dena R Shibib, Michael O Vernon

Abstract readReview
In one paragraph

Review in American journal of infection control, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sanchita DasDepartment of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, IL; Department of Infection Control, NorthShore University HealthSystem, Evanston, IL. Electronic address: SDas@northshore.org.
Dena R ShibibDepartment of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, IL; Department of Pathology, The University of Chicago Medicine, Chicago, IL.
Michael O VernonDepartment of Infection Control, NorthShore University HealthSystem, Evanston, IL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in technology over the last decade have propelled the microbiology laboratory into a pivotal role in infection prevention and control. The rapid adaptation of molecular technologies to the field of clinical microbiology now greatly influences infectious disease management and significantly impacts infection control practices. This review discusses recent developments in molecular techniques in the diagnosis of infectious diseases. It describes the basic concepts of molecular assays, discusses their advantages and limitations, and characterizes currently available commercial assays with respect to cost, interpretive requirements, and clinical utility.

Indexed as

Cross InfectionEpidemiological MonitoringHumansInfection ControlMolecular Diagnostic TechniquesInfection controlMicrobiologyMolecular assays

Identifiers

PMID28159066
PMCPMC7115290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.